Ascent Wealth Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10.6M Buy
+9,135
New +$10.8M 1.04% 24
2026
Q2
– Sell
-8,706
Closed -$8.01M – 201
2026
Q1
$8.01M Buy
8,706
+540
+7% +$547K 0.93% 33
2025
Q4
$8.78M Buy
8,166
+40
+0.5% +$38.2K 1.01% 31
2025
Q3
$6.2M Buy
8,126
+4,962
+157% +$3.69M 0.72% 45
2025
Q2
$2.47M Sell
3,164
-875
-22% -$680K 0.3% 69
2025
Q1
$3.34M Buy
4,039
+30
+0.7% +$25K 0.45% 54
2024
Q4
$3.09M Buy
4,009
+119
+3% +$98.5K 0.42% 55
2024
Q3
$3.45M Buy
3,890
+599
+18% +$539K 0.48% 49
2024
Q2
$2.98M Buy
3,291
+1,699
+107% +$1.36M 0.44% 53
2024
Q1
$1.21M Buy
+1,592
New +$1.13M 0.18% 102

Other funds holding LLY

Ascent Wealth Partners's LLY Position: Q3 2026 in Review

Ascent Wealth Partners opened a new position in Eli Lilly (LLY) in Q3 2026: 9,135 shares worth $10.6M. The stake represents 1.04% of the portfolio and ranks #24 among its holdings. This is a return to the name: Ascent Wealth Partners previously reported a position in LLY as recently as Q1 2026.

Ascent Wealth Partners first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. 1,515 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Ascent Wealth Partners held 9,135 shares of Eli Lilly worth $10.6M as of Q3 2026.
  • Eli Lilly was a new Ascent Wealth Partners position in Q3 2026.
  • Eli Lilly made up 1.04% of Ascent Wealth Partners's portfolio in Q3 2026, its #24 holding.
  • Ascent Wealth Partners first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
  • 1,515 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Ascent Wealth Partners's 13F filing for Q3 2026, filed 23 Oct 2026.